CIDEX™ 2266Recalls & reported problems

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10705037044580), received between Jun 15, 2018 and Jun 15, 2018 — classified as 1 injury.

The most frequently reported specific device problem is “Device Reprocessing Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

• InjuryJun 15, 2018Device Reprocessing Problem; Failure to Disinfect; Device Reprocessing Problem; Failure to Disinfect

  ADVANCED STERILIZATION PRODUCTS (ASP) BECAME AWARE A PATIENT TESTED (B)(6) FOR (B)(6) AND WAS DIAGNOSED IN (B)(6) 2013 WITH ACQUIRED IMMUNE DEFICIENCY SYNDROME. IT WAS REPORTED A COLONOSCOPY PROCEDURE WAS PERFORMED IN (B)(6) 2011, USING AN OLYMPUS COLONOSCOPE (NON-ASP PRODUCT) WHICH WAS REPROCESSED IN CIDEX SOLUTION. ON (B)(6) 2004 (REVISED ON (B)(6) 2004), ATS LABS PREPARED PROTOCOL # (B)(6) FOR ASP, TITLED ¿VIRUCIDAL EFFICACY OF DISINFECTANTS FOR USE ON INANIMATE ENVIRONMENTAL SURFACES ¿ VIRUS: (B)(6) TYPE 1¿. THE CONCLUSION OF THIS STUDY WAS THAT CIDEX DEMONSTRATED COMPLETE INACTIVATION OF (B)(6) TYPE 1 AS REQUIRED BY THE UNITED STATES (B)(4) FOR VIRUCIDAL LABEL CLAIMS. ASP MADE A DECISION TO FILE A FDA MEDWATCH REPORT OUT OF AN ABUNDANCE OF CAUTION; HOWEVER, ASP DOES NOT BELIEVE THE PATIENT DIAGNOSIS WAS RELATED TO USE OF CIDEX DURING SCOPE REPROCESSING.

  Patient problems: HIV, Human Immunodeficiency Virus

  MAUDE report 7606148 ↗